ELISA KITS FOR SARS-COV-2 / COVID-19
Understanding the novel coronavirus and curbing the spread of COVID-19 requires a diverse array of reagents. One of the most important tools is Enzyme-Linked Immunosorbent Assays (ELISAs), qualitative and quantitative tests for the detection of different molecules. In the case of SARS-COV-2 and COVID-19, these kits detect patient immunoglobulins against viral proteins to assess immunity. Emerging evidence suggests that hyperactivity of the immune system after SARS-COV-2 infection can trigger excessive release of cytokines such as IL-6, TNF alpha and IFN gamma. This rapid immune escalation is called the cytokine storm syndrome and can lead to severe lung damage and death.